Multimodal treatment for stage IVA thymoma: A proposable strategy

Lung Cancer

Volumn 76, Issue 1, 2012, Pages 89-92

  Rena, Ottavio ^a   Mineo, Tommaso Claudio ^b   Casadio, Caterina ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Chemotherapy; Multimodal treatment; Radiotherapy; Surgery; Survival; Thymoma

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LOBECTOMY; LUNG RESECTION; LUNG WEDGE PRESSURE; MALE; MINIMAL RESIDUAL DISEASE; MORBIDITY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PLEURECTOMY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION FIELD; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; THYMECTOMY; THYMOMA; TREATMENT RESPONSE;

ADULT; AGED; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE PERIOD; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMOMA; THYMUS NEOPLASMS;

EID: 84858002770     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.10.004     Document Type: Article

References (20)

1. Masaoka A., Monden Y., Nakahara K., Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981, 48:2485-2492.
2. Blumberg D., Port J.L., Weksler B., Delgado R., Rosai J., Bains M.S., et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995, 60:908-914.
3. Kondo K., Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003, 75:878-885.
4. Nakagawa K., Asamura H., Matsuno Y., Suzuki K., Kondo H., Maeshima A., et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003, 126:1134-1140.
5. Rena O., Papalia E., Maggi G., Oliaro A., Ruffini E., Filosso P.L., et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 2005, 50:59-66.
6. Huang J., Rizk N.P., Travis W.D., Seshan V.E., Bains M.S., Dycoco J., et al. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 2007, 134:1477-1484.
7. Wright C.D. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg 2006, 82:1234-1239.
8. Lucchi M., Ambrogi M.C., Duranti L., Basolo F., Fontanini G., Angeletti C.A., et al. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg 2005, 79:1840-1844.
9. Bretti S., Berruti A., Loddo C., Sperone P., Casadio C., Tessa M., et al. Piemonte Oncology Network. Multimodal management of stages III-IVA malignant thymoma. Lung Cancer 2004, 44:69-77.
10. Kim E.S., Putnam J.B., Komaki R., Walsh G.L., Ro J.Y., Shin H.J., et al. Phase II study of multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 2004, 44:369-379.
11. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart 2004, IARC Press, Lyon. W.D. Travis, E. Brambilla, H.K. Mueller-Hermelink, C.C. Harris (Eds.).
12. RECIST. The National Cancer Institute. Response evaluation criteria in solid tumors, Available from: ; 2000. http://ctep.cancer.gove/guidelines/recist.html.
13. Nakahara K., Ohno K., Hashimoto J., Maeda H., Miyoshi S., Sakurai M., et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988, 95:1041-1047.
14. Maggi G., Casadio C., Cavallo A., Cianci R., Molinatti R., Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991, 51:152-156.
15. Pan C.C., Wu H.P., Yang C.F., Chen W.Y., Chiang H. The clinicopathological correlations of epithelial subtyping in thymoma: a study of 112 consecutive cases. Hum Pathol 1994, 25:893-899.
16. Regnard J.F., Magdeleinat P., Dromer C., Dulmet E., de Montpreville V., Levi J.F., et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996, 112:367-384.
17. Yagi K., Hirata T., Fukuse T., Yokomise H., Inui K., Ike O., et al. Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 1996, 61:521-544.
18. Wilkins K.B., Shiekh E., Green R., Patel M., George S., Takano M., et al. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 1999, 230:562-574.
19. Sperling B., Marshall J., Kennedy R., Pahwa P., Chibbar R. Thymoma: a review of the clinical and pathological findings in 65 cases. Can J Surg 2003, 46:37-42.
20. Belcher E., Hardwick T., Lal R., Marshall S., Spicer J., Lang-Landunski L. Induction chemotherapy, cytoreductive surgery and intraoperative hyperthermic pleural irrigation in patients with stage IVA thymoma. Interact Cardiovasc Thorac Surg 2011, 12:744-748.